Richard Strafehl, CEO, Safeguard Biosystems

Mr. Strafehl comments on the major obstacles facing genomics researchers today and discusses the remarkable speed at which genomics science is progressing in Ontario.

Dx2010 Markers to Market brought together leading international researchers, regulatory representatives and entrepreneurs from the diagnostics sector to examine regulatory hurdles and commercialization challenges on the path from biomarker discovery to market for molecular diagnostics and prognostics. Dx2010 Markers to Market was co-hosted by the Ontario Genomics Institute and MaRS.

MaRS - Building Canada’s next generation of global technology companies.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…